Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04397029 · ClinicalTrials.gov registry record · NA
Assessing the Sensitivity of "SureTouch™" in Women Undergoing Diagnostic and Screening Mammography
A NA study, sponsored by George Washington University.
- Terminated
- Registry status
- NA
- Development phase
- 213
- Enrollment target
NCT04397029 is a NA study that was terminated before completion, run by George Washington University. The registered enrollment target is 213 participants.
The verdict
NCT04397029, a NA study, was terminated before completion, sponsored by George Washington University.
- TERMINATED
- Registry status
- NA
- Development phase
- 213 participants
- Enrollment target
Study Summary
Prospective, case-control study being conducted to determine the sensitivity of the SureTouch device in detecting known masses at a pre-determined level of specificity.
Interventions
- DEVICE SureTouch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2019-01-04 |
| Est. Completion | 2021-02-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04397029
The ClinicalTrials.gov registry entry for NCT04397029 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 213 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Washington University, which has 133 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SureTouch is the first listed.
NCT04397029 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04397029 about?
NCT04397029 is a clinical study titled "Assessing the Sensitivity of "SureTouch™" in Women Undergoing Diagnostic and Screening Mammography". Prospective, case-control study being conducted to determine the sensitivity of the SureTouch device in detecting known masses at a pre-determined level of specificity.
What is the current status of trial NCT04397029?
This trial is currently terminated. It is a NA study. The enrollment target is 213 participants. The study started on 2019-01-04. Estimated completion is 2021-02-10.
What interventions are being tested in trial NCT04397029?
The interventions under investigation include: SureTouch (DEVICE).
Who is sponsoring clinical trial NCT04397029?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.